Skip to main content
. 2021 Jul 26;7(3):00045-2021. doi: 10.1183/23120541.00045-2021

TABLE 1.

Baseline characteristics of the patients (n=141)

Characteristic Result
Age years
 Median 69 (60–74)
 Range 26–85
Sex
 Female 55 (39.0)
 Male 86 (61.0)
Smoking status
 Never smoker 55 (39.0)
 Current smoker 23 (16.3)
 Previous smoker 63 (44.7)
Pulmonary function tests
 FEV1 L 2.5 (2.0–2.9)
 FEV1 % pred 89.0 (76.0–98.0)
 FVC L 3.1 (2.6–3.7)
 FVC % pred 87.1 (77.8–102.0)
 TLC L 4.8 (4.1–5.6)
 TLC % pred 77.0 (68.2–86.0)
DLCO % pred 57.0 (40.0–64.0)
 6MWD m 435 (99–520)
Primary presumptive diagnosis prior to TBCB
 UIP/IPF 49 (34.5)
 NSIP 23 (16.2)
 HP 17 (12.0)
 CTD-ILD 16 (11.3)
 Unclassified ILD 14 (9.9)
 Unclassifiable ILD 7 (4.9)
 Other 15 (10.6)
TBCB biopsy site
 Right upper lobe 0 (0)
 Right middle lobe 2 (1.4)
 Right lower lobe 124 (87.9)
 Left upper lobe 0 (0)
 Left lower lobe 15 (10.6)

Date are presented as n–n, n (%) or median (IQR) unless otherwise stated. FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; TLC: total lung capacity; DLCO: diffusing capacity of the lung for carbon monoxide; 6MWD: 6-min walk distance; TBCB: transbronchial cryobiopsy; UIP: usual interstitial pneumonia; IPF: idiopathic pulmonary fibrosis; NSIP: nonspecific interstitial pneumonia; HP: hypersensitivity pneumonitis; CTD-ILD: connective tissue disease-associated ILD.